Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 1 de 1
1.
Neurochirurgie ; 64(6): 439-441, 2018 Dec.
Article En | MEDLINE | ID: mdl-30274919

Erdheim-Chester disease is a rare form of non-Langerhans cell histiocytosis. It is an inflammatory disorder associated with BRAF V600E mutation in 50% of cases. This multisystem disease is rarely associated with spinal involvement. Neurological involvement is an independent predictive factor of poor prognosis. The diagnosis is histopathological based on CD68-positive and CD1A-negative histiocytes. Treatment with interferon-alpha is an independent predictor of survival in Erdheim-Chester disease and vemurafenib has also been shown to be effective for BRAF V600E mutation. We report a clinical case of a 51-year-old patient with multiple and rare locations of Erdheim-Chester disease, particularly at the sphenoid sinus.


Erdheim-Chester Disease/genetics , Mutation/genetics , Proto-Oncogene Proteins B-raf/genetics , Spinal Cord Compression/genetics , Erdheim-Chester Disease/diagnosis , Humans , Interferon-alpha/metabolism , Middle Aged , Sphenoid Sinus/surgery , Spinal Cord Compression/diagnosis
...